Venofer 200 mg Infusions: 14-Day Interval for Non-Dialysis CKD Patients
For adult patients with non-dialysis dependent chronic kidney disease (NDD-CKD), Venofer 200 mg infusions should be administered on 5 different occasions over a 14-day period 1.
Dosing Schedule by Patient Population
The interval between Venofer infusions varies significantly based on the patient's dialysis status:
Non-Dialysis Dependent CKD (NDD-CKD)
- 200 mg doses: Administer on 5 different occasions over 14 days 1
- This translates to approximately every 2-3 days during the treatment course
- Alternative high-dose regimen: 500 mg on Day 1 and Day 14 only (limited experience) 1
Hemodialysis Dependent CKD (HDD-CKD)
- 100 mg per consecutive hemodialysis session 1
- Typically administered 2-3 times weekly depending on dialysis schedule
- Total course: 1000 mg over multiple sessions
Peritoneal Dialysis Dependent CKD (PDD-CKD)
- 300 mg infusions: Two doses given 14 days apart 1
- Followed by 400 mg 14 days later (third dose)
- Total treatment delivered over 28 days
Clinical Context from Research
Research supports the FDA-approved intervals. Studies in peritoneal dialysis patients demonstrated that 200 mg weekly for 4 weeks, then 200 mg every other week effectively maintained hemoglobin and iron parameters 2, 3. A maintenance study showed that even 100 mg monthly could sustain iron stores in stable PD patients 4.
For NDD-CKD specifically, the 5-dose regimen over 14 days (200 mg each) provides rapid iron repletion compared to oral therapy, with significant improvements in hemoglobin and ferritin within 4 weeks 5.
Important Caveats
- Monitor for hypersensitivity reactions for at least 30 minutes after each infusion 1
- The compressed 14-day schedule for NDD-CKD patients requires 5 separate clinic visits, which may impact adherence
- Do not exceed recommended intervals - spacing doses too closely increases risk of adverse reactions without improving efficacy
- Treatment may be repeated if iron deficiency recurs after completing the initial course 1
The FDA labeling is explicit and should guide practice: for your NDD-CKD patient population, the answer is definitively 5 doses over 14 days, not a fixed number of days between each individual dose.